trending Market Intelligence /marketintelligence/en/news-insights/trending/2exPEBgLA-TxnyAShTnoqA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Moody's downgrades Meinian Onehealth's credit rating; outlook negative

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Moody's downgrades Meinian Onehealth's credit rating; outlook negative

Moody's downgraded Meinian Onehealth Healthcare Holdings Co. Ltd.'s corporate family credit rating to Ba3 from Ba2.

The rating agency also changed its outlook on the Shanghai-based healthcare services provider to negative from a so-called review for downgrade, signifying a further rating cut could take place in the future.

Moody's action reflects the agency's view that Meinian Onehealth's leverage — a measure of borrowed money to expand or run a business — will remain high over the next 12 to 18 months and will not be offset by an increase in revenues.

The rating agency expects Meinian Onehealth's revenue to grow between 15% to 18% over the next 12 to 18 months, lower than the 30% growth rate expected previously given a decline in the company's medical center utilization. The company had introduced a new appointment service system, which, while improving customer experience, limits the number of visits per medical center.

The lower growth trajectory, combined with larger-than-expected investments to improve service quality, as well as higher expenses related to training and compensation, is likely to lead to a lower-than-expected margin, said the rating agency.

Moody's expects Meinian Onehealth's adjusted debt to EBITDA ratio — the ability to pay down debt before certain items — to increase to a multiple of 4 to 4.5 over the next 12 to 18 months.

Moody's said it could change the outlook back to stable if Meinian Onehealth adequately improves its liquidity position over the next six to 12 months, among other things.